Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 1997

View Archived Issues

New antitumor agent from Teikoku Hormone characterized in mice

Promising data with Parkinson's disease diagnostic reported

COX-2 inhibitors from Merck Frosst

Janssen and Neurocrine Biosciences disclose CRF antagonists

Astra discloses iNOS inhibitors

Tachykinin antagonists prepared by Merck & Co.

Cerebroprotective activity of novel free radical scavenger established in animal model

Preclinical neuroprotective activity of P&U antioxidants

Merck & Co. fibrinogen antagonist characterized in animals

New pharmacological data reported for Novo Nordisk/Lilly muscarinic agent

Nymox Pharmaceuticals outlines R&D pipeline

Nycomed: Q1 1997 highlights

Salix Holdings: Q1 1997 highlights

Fujisawa: FY 1997 highlights

DHEA enters phase II/III trials

Aciclovir demonstrates antiasthmatic activity in animal model

Multinational trial assesses efficacy and safety of tolterodine for incontinence

Generic aciclovir approved by FDA

DepoTech reacquires certain marketing rights to DepoCyt

IVIg for acute cardiomyopathy

Development of anti-cytokine antibody product for RA progresses

Millennium BioTherapeutics discovers novel chemokine implicated in brain inflammation

Xytronyx's Periodontal Tissue Monitor nears U.S. approval

Preclinical validation of Techniclone's Vasopermeation Enhancement technology

Inflazyme granted Australian patent for antiinflammatory agents

Palatin's LeuTech demonstrates rapid and accurate imaging of sites of infection

TKT reaches milestone in second Gene Activation collaboration with HMR

Copernicus Gene Systems and Inex establish gene delivery collaboration

Transdermal buspirone patch shows encouraging results in ADHD

Promising clinical results reported for Flt3 ligand as stem cell mobilizer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...